InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Incannex Healthcare Inc.

IXHL Clue Score34
United States Fiscal year ends June CIK 0001873875
$3.10 -3.13% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $3.10 +638.45% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 30 Nov 2023. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2020Revenue0.6Net income−4.7EPS, diluted−0.57Fiscal year 2021Revenue1.9 +213.7%Net income−11.4EPS, diluted−1.16Fiscal year 2022Net income−14.9EPS, diluted−1.25Fiscal year 2023Operating income−49.7Net income−48.8EPS, diluted−3.32Fiscal year 2024Revenue0.0Operating income−30.0Net income−18.5EPS, diluted−1.15Fiscal year 2025Revenue0.1 +616.7%Operating income−23.8Net income−46.9EPS, diluted−40.82Fiscal year 2026Revenue0.0 −100.0%Operating income−23.0Net income−19.3EPS, diluted−1.66
FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue 0.6 1.9 n/a n/a 0.0 0.1 0.0
Growth +213.7% +616.7% −100.0%
Operating income n/a n/a n/a −49.7 −30.0 −23.8 −23.0
Net income −4.7 −11.4 −14.9 −48.8 −18.5 −46.9 −19.3
Growth
EPS, diluted −0.57 −1.16 −1.25 −3.32 −1.15 −40.82 −1.66

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2020Net margin−776.6%Fiscal year 2021Net margin−599.3%Fiscal year 2022Fiscal year 2023Fiscal year 2024Operating margin−250,341.7%Net margin−153,825.0%Free cash flow margin−134,350.0%Fiscal year 2025Operating margin−27,661.6%Net margin−54,517.4%Free cash flow margin−14,559.3%Fiscal year 2026
FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Operating margin n/a n/a n/a n/a −250,341.7% −27,661.6% n/a
Net margin −776.6% −599.3% n/a n/a −153,825.0% −54,517.4% n/a
Free cash flow margin n/a n/a n/a n/a −134,350.0% −14,559.3% n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2020Operating cash flow−3.9Fiscal year 2021Operating cash flow−6.9Fiscal year 2022Operating cash flow−12.8Fiscal year 2023Operating cash flow−10.7Capital expenditure−0.3Free cash flow−11.1Fiscal year 2024Operating cash flow−15.8Capital expenditure−0.3Free cash flow−16.1Fiscal year 2025Operating cash flow−12.5Capital expenditure−0.0Free cash flow−12.5Buybacks0.0Fiscal year 2026Operating cash flow−12.9Capital expenditure−0.0Free cash flow−12.9Buybacks−9.4
FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Operating cash flow −3.9 −6.9 −12.8 −10.7 −15.8 −12.5 −12.9
Capital expenditure n/a n/a n/a −0.3 −0.3 −0.0 −0.0
Free cash flow n/a n/a n/a −11.1 −16.1 −12.5 −12.9
Growth
Buybacks n/a n/a n/a n/a n/a 0.0 −9.4

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2020Cash3.6Shareholders’ equity3.2Fiscal year 2021Cash9.1Shareholders’ equity8.6Fiscal year 2022Cash25.8Shareholders’ equity24.7Fiscal year 2023Cash22.1Shareholders’ equity20.8Fiscal year 2024Cash5.9Shareholders’ equity11.2Fiscal year 2025Cash15.0Shareholders’ equity13.4Fiscal year 2026Cash67.7Shareholders’ equity67.4
FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash 3.6 9.1 25.8 22.1 5.9 15.0 67.7
Shareholders’ equity 3.2 8.6 24.7 20.8 11.2 13.4 67.4

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2026 · 10-K

Balance sheet

In millions of USD, except per-share figures; shares in millions. Fiscal years ending June, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2020 30 Jun 2020 FY2021 30 Jun 2021 FY2022 30 Jun 2022 FY2023 30 Jun 2023 FY2024 30 Jun 2024 FY2025† 30 Jun 2025 FY2026† 30 Jun 2026
Assets
3.6 9.1 25.8 22.1 5.9 15.0 67.7
0.4 0.2 0.3 0.3 n/a n/a n/a
n/a n/a n/a 0.3 0.5 0.2 0.0
4.2 9.3 37.9 88.6 n/a n/a n/a
Growth +120.2% +306.1% +133.9%
Liabilities
1.1 0.8 2.0 4.5 n/a n/a n/a
Equity
−32.5 −43.9 −58.8 −92.2 −110.7 −157.6 −176.9
3.2 8.6 24.7 20.8 11.2 13.4 67.4
Growth +170.9% +188.2% −15.7% −46.1% +19.4% +403.2%
Per share and net cash
n/a n/a 1,292 1,587 17.6 6.5 12.5
calc n/a n/a 0.02 0.01 0.64 2.07 5.37

† The diluted share count jumps at 2025 and 2026, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Lines marked calc are worked out here from filed figures; point at one for how.